Mostrar el registro sencillo del ítem

dc.contributor.authorInfantes-Lorenzo, Jose Antonio 
dc.contributor.authorMoreno-Iruela, Inmaculada 
dc.contributor.authorRisalde, María de Los Ángeles
dc.contributor.authorRoy, Alvaro
dc.contributor.authorVillar, Margarita
dc.contributor.authorRomero, Beatriz
dc.contributor.authorIbarrola, Nieves
dc.contributor.authorde la Fuente, José
dc.contributor.authorPuentes, Eugenia
dc.contributor.authorJuan, Lucía de
dc.contributor.authorGortázar, Christian
dc.contributor.authorBezos, Javier
dc.contributor.authorDomínguez, Lucas
dc.contributor.authorDominguez-Rodriguez, Mercedes 
dc.date.accessioned2019-02-18T12:29:41Z
dc.date.available2019-02-18T12:29:41Z
dc.date.issued2017-11
dc.identifier.citationClin Proteomics. 2017 Nov 2;14:36.es_ES
dc.identifier.issn1542-6416es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7176
dc.description.abstractBackground: Bovine purified protein derivative (bPPD) and avian purified protein derivative (aPPD) are widely used for bovine tuberculosis diagnosis. However, little is known about their qualitative and quantitative characteristics, which makes their standardisation difficult. In addition, bPPD can give false-positive tuberculosis results because of sequence homology between Mycobacterium bovis (M. bovis) and M. avium proteins. Thus, the objective of this study was to carry out a proteomic characterisation of bPPD, aPPD and an immunopurified subcomplex from bPPD called P22 in order to identify proteins contributing to cross-reactivity among these three products in tuberculosis diagnosis. Methods: Trypsin digests of bPPD, aPPD and P22 were analysed by nanoscale liquid chromatography-electrospray ionization tandem mass spectrometry. Mice were immunised with bPPD or aPPD, and their serum was tested by indirect ELISA for reactivity against these preparations as well as against P22. Results: A total of 456 proteins were identified in bPPD, 1019 in aPPD and 118 in P22; 146 of these proteins were shared by bPPD and aPPD, and 43 were present in all three preparations. Candidate proteins that may cause cross-reactivity between bPPD and aPPD were identified based on protein abundance and antigenic propensity. Serum reactivity experiments indicated that P22 may provide greater specificity than bPPD with similar sensitivity for ELISA-type detection of antibodies against M. tuberculosis complex. Conclusion: The subpreparation from bPPD called P22 may be an alternative to bPPD for serodiagnosis of bovine tuberculosis, since it shares fewer proteins with aPPD than bPPD does, reducing risk of cross-reactivity with anti-M. avium antibodies.es_ES
dc.description.sponsorshipThis work was supported by the Ministerio de Economía, Industria y Competitividad of Spain (RTC-2016-4746-2), the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria of Spain (RTA2015-00043-C02-02) and the TAVS-CM Programme of the Comunidad de Madrid (S2013/ABI-2747), cofinanced by the FEDER fund “A way to build Europe”. Jose Antonio Infantes-Lorenzo was supported by an FPU contract-fellowship (Formación de Profesorado Universitario) from the Ministerio de Educación, Cultura y Deporte of the Spanish Government (FPU2013/6000). Alvaro Roy is the recipient of an Industrial Doctorate contract (DI-15-08110) funded by the Spanish Ministerio de Economía, Industria y Competitividad and the European Social Fund.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCross-reactiones_ES
dc.subjectP22es_ES
dc.subjectPPDes_ES
dc.subjectProteomees_ES
dc.subjectTuberculosises_ES
dc.titleProteomic characterisation of bovine and avian purified protein derivatives and identification of specific antigens for serodiagnosis of bovine tuberculosises_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID29142508es_ES
dc.format.volume14es_ES
dc.format.number1es_ES
dc.format.page36es_ES
dc.identifier.doi10.1186/s12014-017-9171-zes_ES
dc.contributor.funderMinisterio de Economía, Industria y Competitividad (España) 
dc.contributor.funderInstituto Nacional de Investigación y Tecnología Agraria y Alimentaria (España) 
dc.contributor.funderComunidad de Madrid (España) 
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) 
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12014-017-9171-zes_ES
dc.identifier.journalClinical proteomicses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RTC-2016-4746-2es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional